Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 3.200
+0.180 (5.96%)
Jun 19, 2025, 1:53 PM CET
Arctic Bioscience AS Revenue
In the year 2024, Arctic Bioscience AS had annual revenue of 44.40M NOK with 31.55% growth. Arctic Bioscience AS had revenue of 27.20M in the half year ending December 31, 2024, with 35.54% growth.
Revenue
44.40M
Revenue Growth
+31.55%
P/S Ratio
1.83
Revenue / Employee
2.02M
Employees
22
Market Cap
81.12M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 603.92M |
| Nordhealth AS | 545.88M |
| Photocure ASA | 532.69M |
| Vistin Pharma ASA | 440.66M |
| Omda AS | 442.14M |
| Gentian Diagnostics ASA | 158.07M |
| ArcticZymes Technologies ASA | 102.97M |
| Lytix Biopharma AS | 608.00K |